Jos Perriens

TL;DR: A public-health approach to antiretroviral therapy (ART) to enable scaling-up access to treatment for HIV-positive people in developing countries, recognising that the western model of specialist physician management and advanced laboratory monitoring is not feasible in resource-poor settings.

TL;DR: The 3 by 5 initiative did show that with the right vision and a determined effort by all relevant parties development achievements that seem unthinkable are indeed possible and the progress on access to antiretroviral treatment might have no precedent in global public health.

TL;DR: In a prospective study of adult admissions to the Department of Internal Medicine at Mama Yemo Hospital, Kinshasa, Zaire in late 1988, 129 women and 122 men screened for HIV infection were found to be seropositive, with half of the seropositives meeting the World Health Organization (WHO) clinical AIDS definition.

TL;DR: In this article, the authors argue that the situation in developing countries, where few patients have been previously exposed to suboptimal drug regimens and where a public health approach may be taken to the treatment of HIV infection, is in many respects more favorable to the prevention of widespread viral drug resistance than that in the developed world.

TL;DR: The 2013 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection at country level target the entire continuum of care for the HIV-infected individual, and in some cases, their partners, and those with unknown status.